Barclays PLC Ironwood Pharmaceuticals Inc Call Options Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$8.32 - $15.45 $1.37 Million - $2.55 Million	165,000 Added 142.49%	280,800 $2.45 Million
Q4 2023 Feb 15, 2024	SELL	$8.79 - $11.51 $427,193 - $559,386	-48,600 Reduced 29.56%	115,800 $1.33 Million
Q3 2023 Nov 07, 2023	BUY	$8.25 - $11.35 $1.36 Million - $1.87 Million	164,400 New	164,400 $1.58 Million
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $12,070 - $14,870	1,000	1,000 $16,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $530M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.